Page last updated: 2024-11-03

pyrilamine and Parkinson Disease

pyrilamine has been researched along with Parkinson Disease in 1 studies

Pyrilamine: A histamine H1 antagonist. It has mild hypnotic properties and some local anesthetic action and is used for allergies (including skin eruptions) both parenterally and locally. It is a common ingredient of cold remedies.
mepyramine : An ethylenediamine derivative that is ethylenediamine in which one of the amino nitrogens is substituted by two methyl groups and the remaining amino nitrogen is substituted by a 4-methoxybenzyl and a pyridin-2-yl group.

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pertz, HH1
Görnemann, T1
Schurad, B1
Seifert, R1
Strasser, A1

Other Studies

1 other study available for pyrilamine and Parkinson Disease

ArticleYear
Striking differences of action of lisuride stereoisomers at histamine H1 receptors.
    Naunyn-Schmiedeberg's archives of pharmacology, 2006, Volume: 374, Issue:3

    Topics: Animals; Antiparkinson Agents; Cell Membrane; Dopamine; Dopamine Agonists; GTP Phosphohydrolases; GT

2006